These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9010024)

  • 1. Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer.
    Pifarré A; Rosell R; Monzó M; De Anta JM; Moreno I; Sánchez JJ; Ariza A; Mate JL; Martińez E; Sánchez M
    Br J Cancer; 1997; 75(2):184-9. PubMed ID: 9010024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors.
    Rosell R; Pifarré A; Monzó M; Astudillo J; López-Cabrerizo MP; Calvo R; Moreno I; Sanchez-Céspedes M; Font A; Navas-Palacios JJ
    Int J Cancer; 1997 Jun; 74(3):330-4. PubMed ID: 9221814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung].
    Sánchez Céspedes M; López Cabrerizo MP; Moreno I; Ariza A; Monzó M; Rosell R
    Med Clin (Barc); 1997 May; 109(1):1-5. PubMed ID: 9303970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
    Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J
    Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal squamous cell carcinomas with DNA replication errors (RER+) are associated with p16/pRb loss and wild-type p53.
    Mathew R; Arora S; Mathur M; Chattopadhyay TK; Ralhan R
    J Cancer Res Clin Oncol; 2001 Oct; 127(10):603-12. PubMed ID: 11599796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer.
    Massa MJ; Iniesta P; González-Quevedo R; de Juan C; Caldés T; Sánchez-Pernaute A; Cerdán J; Torres AJ; Balibrea JL; Benito M
    Eur J Cancer; 1999 Nov; 35(12):1676-82. PubMed ID: 10674012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.
    Schiller JH; Adak S; Feins RH; Keller SM; Fry WA; Livingston RB; Hammond ME; Wolf B; Sabatini L; Jett J; Kohman L; Johnson DH
    J Clin Oncol; 2001 Jan; 19(2):448-57. PubMed ID: 11208838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.
    Tani M; Takenoshita S; Kohno T; Hagiwara K; Nagamachi Y; Harris CC; Yokota J
    Carcinogenesis; 1997 May; 18(5):1119-21. PubMed ID: 9163705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
    Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S
    Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of loss of heterozygosity by microsatellite probe and DNA content analysis].
    Chiba W; Sawai S; Ikeda S; Kinoshita M; Hatama T; Shin S; Fujimoto T; Miyajima S; Wazawa H; Hanawa T
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():158-63. PubMed ID: 7611781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.
    Sakata K
    J Oral Pathol Med; 1996 Jul; 25(6):302-7. PubMed ID: 8887073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
    Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
    J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
    Schneider PM; Praeuer HW; Stoeltzing O; Boehm J; Manning J; Metzger R; Fink U; Wegerer S; Hoelscher AH; Roth JA
    Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
    Chmara M; Wozniak A; Ochman K; Kobierska G; Dziadziuszko R; Sosinska-Mielcarek K; Jassem E; Skokowski J; Jassem J; Limon J
    Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.
    Field JK; Neville EM; Stewart MP; Swift A; Liloglou T; Risk JM; Ross H; Gosney JR; Donnelly RJ
    Br J Cancer; 1996 Dec; 74(12):1968-74. PubMed ID: 8980398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.
    Mitsudomi T; Oyama T; Kusano T; Osaki T; Nakanishi R; Shirakusa T
    J Natl Cancer Inst; 1993 Dec; 85(24):2018-23. PubMed ID: 8246288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.